EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
153 hedge funds and large institutions have $334M invested in Eagle Pharmaceuticals, Inc. in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 53 increasing their positions, 63 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
153
Holders Change
+1
Holders Change %
+0.66%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
53
Reduced
63
Closed
19
Calls
$48K
Puts
$23K
Net Calls
+$25K
Net Calls Change
-$1.74M
